Showing 161 - 180 results of 549 for search '"In Combo"', query time: 0.12s Refine Results
  1. 161

    Cytomegalovirus Diseases of the Gastrointestinal Tract by Pai-Jui Yeh, Ren-Chin Wu, Cheng-Tang Chiu, Ming-Wei Lai, Chien-Ming Chen, Yu-Bin Pan, Ming-Yao Su, Chia-Jung Kuo, Wey-Ran Lin, Puo-Hsien Le

    Published 2022-02-01
    “…Prognostic factors of in-hospital mortality included age, immune status, albumin level, platelet count, GI bleeding, time-to-diagnosis, and Combo therapy. In the survival analysis, immunocompetent patients receiving Combo therapy had the best survival curve, and immunocompromised patients receiving non-Combo therapy had the worst survival curve. …”
    Get full text
    Article
  2. 162

    Exploration of New Optical Solitons in Magneto-Optical Waveguide with Coupled System of Nonlinear Biswas–Milovic Equation via Kudryashov’s Law Using Extended F-Expansion Method by Wafaa B. Rabie, Hamdy M. Ahmed, Walid Hamdy

    Published 2023-01-01
    “…Various types of solutions are extracted, such as dark soliton solutions, singular soliton solutions, a dark–singular combo soliton, singular combo soliton solutions, Jacobi elliptic solutions, periodic solutions, combo periodic solutions, hyperbolic solutions, rational solutions, exponential solutions and Weierstrass solutions. …”
    Get full text
    Article
  3. 163

    Efficacy and drug persistence of baricitinib monotherapy is similar to combination therapy in patients with active RA: a prospective observational study by Georg Schett, Johannes Knitza, Gerhard Krönke, David Simon, Koray Tascilar, Sara Bayat, Daniela Bohr, Fabian Hartmann

    Published 2022-11-01
    “…However, real-world data are scarce regarding efficacy and drug persistence for BARI monotherapy (BARI-mono) versus its combination with MTX (BARI-combo).Objective To evaluate efficacy and drug persistence of BARImono compared with BARI-combo in routine clinical practiceMethods Patients with RA who were switched to BARI were included in a prospective, monocentric cohort. …”
    Get full text
    Article
  4. 164

    Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10 by Mu-Yang Huang, Yu-Chi Chen, Wen-Yu Lyu, Xin-Yu He, Zi-Han Ye, Can-Yu Huang, Xin-Ling He, Xiuping Chen, Xiaobing Chen, Baoxian Zhang, Guoyin Kai, Xiaolei Zhang, Ting Li, Mingqing Huang, Jin-Jian Lu

    Published 2023-12-01
    “…By comparing the anti-cancer effect of combo treatment among MC38, CT26 and 4T1 tumors, resident T cells were considered as a prerequisite for the effectiveness of combo treatment. …”
    Get full text
    Article
  5. 165

    A case study of low price not necessary to create sales of Streamyx Broadband offered by ™ (Telekom Malaysia) Bhd / Nurwasila Ahmad Foad by Ahmad Foad, Nurwasila

    Published 2009
    “…Reveals from finding that there are higher numbers of sales come from package Streamyx Combo 3 that offer 1Mbps with high price and the percentage of product of internet being faulty for Streamyx Combo 3 is the lowest. …”
    Get full text
    Student Project
  6. 166
  7. 167

    TLR7/8/9 agonists and low-dose cisplatin synergistically promotes tertiary lymphatic structure formation and antitumor immunity by Shuting Wu, Rong Xiang, Yiwei Zhong, Shushu Zhao, Zhiyu Zhang, Zhihua Kou, Shijie Zhang, Yi Zhao, Cheng Zu, Gan Zhao, Yanling Xiao, Sulin Ren, Xiaoming Gao, Bin Wang

    Published 2025-01-01
    “…Notably, the combo therapy also suppressed the growth of distant untreated 4T-1 tumors, demonstrating systemic antitumor effects. …”
    Get full text
    Article
  8. 168

    Performance of three multi-species rapid diagnostic tests for diagnosis of <it>Plasmodium falciparum </it>and <it>Plasmodium vivax </it>malaria in Oromia Regional State, Ethiopia by Yadeta Damtew, Counihan Helen, Tesfaye Gezahegn, Kefyalew Takele, Ashton Ruth A, Cundill Bonnie, Reithinger Richard, Kolaczinski Jan H

    Published 2010-10-01
    “…CareStart had higher specificity in detecting <it>P. vivax </it>(97.2%) than both ParaScreen and ICT Combo (p < 0.001 and p = 0.05, respectively). Health extension workers preferred CareStart and ParaScreen to ICT Combo due to the clear labelling of bands on the cassette, while the 'lab in a pack' style of CareStart was the preferred design. …”
    Get full text
    Article
  9. 169

    Sodium hydroxide enhances the efficacy of rapamycin to suppress proliferation of Tsc2-null mouse embryonic fibroblasts by LI Kai, WANG Ya-nan

    Published 2021-07-01
    “…But the level of p-S6 and p-4EBP1 of Tsc2-/- cells in Combo group was significantly lower than those in NaOH group (P<0.05). …”
    Get full text
    Article
  10. 170

    Efficacy of a topical product combining esafoxolaner, eprinomectin and praziquantel against bedbug (Cimex lectularius) experimental infestations in cats by Tielemans Eric, Rautenbach Carin, Besselaar JF, Beugnet Frederic

    Published 2022-01-01
    “…Two groups of 7 cats were formed: an untreated control group, and a NexGard® Combo group treated once on Day 0 at the label dose. …”
    Get full text
    Article
  11. 171

    On some novel solution solutions to the generalized Schrödinger-Boussinesq equations for the interaction between complex short wave and real long wave envelope by Dipankar Kumar, Kamyar Hosseini, Mohammed K.A. Kaabar, Melike Kaplan, Soheil Salahshour

    Published 2022-08-01
    “…Novel complex hyperbolic and trigonometric function solutions are expressed by the dark, bright, combo dark-bright, W-shaped, M-shaped, singular, combo singular, and periodic wave solutions. …”
    Get full text
    Article
  12. 172

    Natural product based anticancer drug combination discovery assisted by deep learning and network analysis by Elton L. Cao

    Published 2024-01-01
    “…DeepNPD notably identified Thioguanine and Hydroxyurea and DeepCombo discovered Vinblastine and Dasatinib as hits for potential new anticancer drug combinations. …”
    Get full text
    Article
  13. 173
  14. 174

    Combined Rehabilitation with Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferolin Discogenic Sciatica in Young People: A Randomized Clinical Trial by Dalila Scaturro, Fabio Vitagliani, Sofia Tomasello, Cristiano Sconza, Stefano Respizzi, Giulia Letizia Mauro

    Published 2023-12-01
    “…At T2, the Combo group showed statistically superior results compared to the other groups only for pain (<i>p</i> < 0.05) and quality of life (<i>p</i> < 0.05). …”
    Get full text
    Article
  15. 175

    Implementasi Teknik Vokal Luk, Gregel dan Crooning dalam Repertoar Tristeza by Galuh Adi Anindhita, Siswanto siswanto, Agnes Tika Setiarini, Leny Suryani

    Published 2023-10-01
    “…Penulisan ini membahas tentang bagaimana implementasi teknik vokal luk, gregel, dan crooning pada repertoar Tristeza dengan iringan combo keroncong. Teknik vokal luk, dan gregel merupakan teknik vokal yang digunakan dalam menyanyikan repertoar keroncong. …”
    Get full text
    Article
  16. 176
  17. 177

    Performance of eight predictive models for hepatocellular carcinoma recurrence after liver transplantation: A comparative study by Ajacio Bandeira de Mello Brandão, Santiago Rodriguez, Cláudio Augusto Marroni, Alfeu de Medeiros Fleck Junior, Matheus V. Fernandes, Marcos Mucenic

    Published 2024-03-01
    “…Results: The R3-AFP score, UCLA nomogram, AFP model, RETREAT, Combo MORAL, and Post-MORAL models exhibited comparable AUROCs, ranging from 0.785 to 0.733. …”
    Get full text
    Article
  18. 178

    Weak gravitational lensing and intrinsic galaxy alignments by Heymans, C

    Published 2003
    “…Model-fitting provides a good alternative to the standard scite{KSB} method (KSB), and comparisons between the two techniques are drawn from an analysis of deep {it R} band imaging from the COMBO-17 survey, revealing strong evidence for the presence of bias in KSB galaxy shape measurement. …”
    Thesis
  19. 179
  20. 180

    INAPTIDÃO SOROLÓGICA DE DOADORES DE SANGUE DO HEMOCENTRO DO HOSPITAL DAS CLÍNICAS DE BOTUCATU by BD Pedro, VCS Emygdio, PC Garcia-Bonichini, AB Castro, CL Miranda, FA Oliveira

    Published 2024-10-01
    “…Desse modo, ao analisar retrospectivamente os relatórios estatísticos no período de Janeiro de 2021 à Março de 2024, observou-se que em 2021 a média anual para os parâmetros testados correspondem à Sífilis 52,94%, Chagas 5,60%, HBsAg 6,80%, Anti-HBC 27,52%, Anti-HCV 13,95%, HIV Combo 8,02%, HTLV I/II 6,50%, em 2022: Sífilis 36,28%, Chagas 5,49%, HBsAg 7,23%, Anti-HBC 25,29%, Anti-HCV 13,18%, HIV Combo 2,88%, HTLV I/II 10,07%, em 2023: Sífilis 44,70 %, Chagas 3,06%, HBsAg 6,51%, Anti-HBC 18,23%, Anti-HCV 12,15%, HIV Combo 4,08%, HTLV I/II 8,69% e em 2024/Abril: Sífilis 45,50%, Chagas 5,00%, HBsAg 0%, Anti-HBC 22,25%, Anti-HCV 17,17%, HIV Combo 3,50%, HTLV I/II 6,58%. …”
    Get full text
    Article